Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa

Around 2.5 million HIV-infected individuals failing first-line therapy qualify for boosted protease inhibitor (bPI)-based second-line therapy globally. Major resistance mutations are rarely present at treatment failure in patients receiving bPI and the determinants of failure in these patients remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutherland, Katherine A., Goodall, Ruth L., McCormick, Adele, Kapaata, Anne, Lyagoba, Fred, Kaleebu, Pontiano, Thiltgen, Geant, Gilks, Charles F., Spyer, Moira, Kityo, Cissy, Pillay, Deenan, Dunn, David, Gupta, Ravindra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Sequence Notes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675176/
https://www.ncbi.nlm.nih.gov/pubmed/26258548
http://dx.doi.org/10.1089/aid.2015.0138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675176/
https://www.ncbi.nlm.nih.gov/pubmed/26258548
http://dx.doi.org/10.1089/aid.2015.0138

Ejemplares similares